全文获取类型
收费全文 | 279篇 |
免费 | 18篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 13篇 |
妇产科学 | 14篇 |
基础医学 | 25篇 |
口腔科学 | 4篇 |
临床医学 | 20篇 |
内科学 | 75篇 |
神经病学 | 46篇 |
特种医学 | 3篇 |
外科学 | 17篇 |
预防医学 | 29篇 |
眼科学 | 2篇 |
药学 | 33篇 |
肿瘤学 | 15篇 |
出版年
2023年 | 6篇 |
2022年 | 10篇 |
2021年 | 15篇 |
2020年 | 14篇 |
2019年 | 9篇 |
2018年 | 8篇 |
2017年 | 5篇 |
2016年 | 4篇 |
2015年 | 4篇 |
2014年 | 12篇 |
2013年 | 13篇 |
2012年 | 22篇 |
2011年 | 19篇 |
2010年 | 9篇 |
2009年 | 12篇 |
2008年 | 25篇 |
2007年 | 17篇 |
2006年 | 22篇 |
2005年 | 14篇 |
2004年 | 10篇 |
2003年 | 19篇 |
2002年 | 7篇 |
2000年 | 1篇 |
1999年 | 1篇 |
1998年 | 3篇 |
1997年 | 1篇 |
1996年 | 3篇 |
1995年 | 1篇 |
1994年 | 1篇 |
1993年 | 1篇 |
1990年 | 1篇 |
1989年 | 2篇 |
1988年 | 1篇 |
1987年 | 1篇 |
1982年 | 1篇 |
1981年 | 1篇 |
1975年 | 1篇 |
1970年 | 1篇 |
排序方式: 共有297条查询结果,搜索用时 62 毫秒
291.
Neuronal antibodies in pediatric epilepsy: Clinical features and long‐term outcomes of a historical cohort not treated with immunotherapy 下载免费PDF全文
292.
Matthew Phillips Başak İnce Hannah Webb Bethan Dalton Catherine McCombie Madeleine Irish Daniela Mercado Gemma Peachey Zohra Zenasni Hubertus Himmerich Paul Robinson Jon Arcelus Sarah Byford Janet Treasure Sabine Landau Vanessa Lawrence Ulrike Schmidt 《European eating disorders review》2023,31(4):489-504
293.
Lacour RA Westin SN Meyer LA Wingo SN Schorge JO Brooks R Mutch D Molina A Sutphen R Barnes M Elder J Teoh D Powell CB Choubey V Blank S Macdonald HR Brady MF Urbauer DL Bodurka D Gershenson DM Lu KH 《Gynecologic oncology》2011,121(2):358-363
Objectives
Previous studies report a survival advantage in ovarian cancer patients with Ashkenazi Jewish (AJ) breast cancer gene (BRCA) founder mutations. The purpose of this study was to determine if this association exists in patients with non-Ashkenazi Jewish (non-AJ) BRCA mutations. We also sought to account for “survival bias” by minimizing lead time that may exist between diagnosis and genetic testing.Methods
Patients with stage III/IV ovarian cancer and a non-AJ BRCA mutation, seen between January 1996 and July 2007, were identified from eight institutions. Patients with sporadic ovarian cancer were compared to similar cases, matched by age, stage, year of diagnosis, and vital status at time interval to BRCA testing. Progression-free (PFS) and overall survival (OS) were calculated by the Kaplan-Meier method. Multivariate Cox proportional hazards models were calculated for variables of interest. Fisher's exact test and chi-square were also used for analysis.Results
Ninety-five advanced stage ovarian cancer patients with non-AJ BRCA mutations and 183 sporadic controls were analyzed. Compared to sporadic ovarian cancer patients, non-AJ BRCA patients had longer PFS (27.9 months vs. 17.9 months, HR 0.61 [95% CI 0.43-0.86]) and OS (101.7 months vs. 54.3 months, HR 0.43 [95% CI 0.27-0.68]). BRCA status was an independent predictor of PFS and OS.Conclusions
This multicenter study demonstrates a significant survival advantage in advanced stage ovarian cancer patients with non-AJ BRCA mutations, confirming the previous studies in the Jewish population. This improved survival was evident when accounting for the “survival bias” that coincides with genetic testing. 相似文献294.
295.
296.
Objective . To examine the comprehensibility, reliability, and validity of a trait measure, the Generalized Self-Efficacy Scale (GSES), among people with arthritis. The scale is designed to measure perceived coping ability across a wide range of demanding situations. Methods . Four studies were conducted. Study 1 tested the comprehensibility of the GSES. Studies 2, 3, and 4 tested the reliability and validity of the modified scale. Data were collected through self-administered questionnaires. Reliability and structure of the GSES were examined using standard item analysis, internal consistency (Cronbach's alpha), test-retest reliability, and factor analyses. Concurrent and predictive validity were examined in relation to demographic, physical, psychological, and social dimensions. Results . The GSES assessed a unitary concept. Higher generalized self-efficacy was associated with greater psychological well-being, both cross-sectionally and longitudinally. The GSES was independent of age and physical health status. Conclusions . The GSES is a reliable and valid measure for use among community-based samples of people with arthritis and may be a useful indicator of general adaptational outcomes. 相似文献
297.
Zoe Anchors Bethan Jones Rachel Thomas Alice Berry Nicola Walsh 《Musculoskeletal care》2023,21(3):655-666